Skip to main content
OpenTrials

Clinical trial condition

Other IDH1-mutated Positive Hematologic Malignancies

Explore clinical trials studying Other IDH1-mutated Positive Hematologic Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Other IDH1-mutated Positive Hematologic Malignancies trial results

Recruiting

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

NCT02074839

Conditions
Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic-AZ Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California-Los Angeles Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions